For condition: Hidradenitis Suppurativa
The Adolescent Hidradenitis Suppurativa Research Study (62 Weeks)
Study Summary
Who Can Participate?
Adolescents aged 12 to under 18 years with hidradenitis suppurativa (HS), may be eligible.
Inclusion Criteria:
• Body weight of 30 kg or more
• Diagnosis of moderate to severe HS for at least 3 months
• Lumps under the skin – total abscess and inflammatory nodule count of at least 5
• Have a documented history of poor response to at least a 3-month course of systemic therapy (oral antibiotic or biologic drug) for
HS (or demonstrated intolerance to or contraindication to a conventional systemic therapy for the treatment of HS)
Participant Info:
• No medical insurance is required to participate
• Study-related medical evaluation and study medication are provided at no cost to the participant or their insurer
• Regular visits with study doctors who are familiar with treating hidradenitis suppurativa
• Will receive investigational oral medication (active study drug)
• Reimbursement for study-related time and travel expenses may be provided
How Long Will The Study Last?
Participation may last about 62 weeks and involve about 14 visits to the study research site.
For more information about this trial, please visit ClinicalTrials.gov
